Cite
HARVARD Citation
Keefe, R. et al. (2021). A randomized Phase II trial evaluating efficacy, safety, and tolerability of oral BI 409306 in attenuated psychosis syndrome: Design and rationale. Early intervention in psychiatry. 15 (5), pp. 1315-1325. [Online].